127 related articles for article (PubMed ID: 23929996)
1. Efficacy of Āyurvedic treatment using Pañcakarma combined with balance exercises for disability and balance in progressive supranuclear palsy.
Jindal N; Shamkuwar MK; Kaur J; Berry S
Anc Sci Life; 2012 Jul; 32(1):54-8. PubMed ID: 23929996
[TBL] [Abstract][Full Text] [Related]
2. A Convenient Prognostic Tool and Staging System for Progressive Supranuclear Palsy.
Golbe LI; Ohman-Strickland P; Beisser EB; Elghoul FT
Mov Disord Clin Pract; 2020 Aug; 7(6):664-671. PubMed ID: 32775512
[TBL] [Abstract][Full Text] [Related]
3. Ayurvedic approach in the management of spinocerebellar ataxia-2.
Singh SK; Rajoria K
Anc Sci Life; 2016; 35(3):167-72. PubMed ID: 27143801
[TBL] [Abstract][Full Text] [Related]
4. Computerized posturography analysis of progressive supranuclear palsy: a case-control comparison with Parkinson's disease and healthy controls.
Ondo W; Warrior D; Overby A; Calmes J; Hendersen N; Olson S; Jankovic J
Arch Neurol; 2000 Oct; 57(10):1464-9. PubMed ID: 11030799
[TBL] [Abstract][Full Text] [Related]
5. The Progressive Supranuclear Palsy Clinical Deficits Scale.
Piot I; Schweyer K; Respondek G; Stamelou M; ; ; ; Sckopke P; Schenk T; Goetz CG; Stebbins GT; Höglinger GU
Mov Disord; 2020 Apr; 35(4):650-661. PubMed ID: 31951049
[TBL] [Abstract][Full Text] [Related]
6. A case study on the Ayurvedic management of cerebral palsy.
Bhinde SM
Anc Sci Life; 2015; 34(3):167-70. PubMed ID: 26120232
[TBL] [Abstract][Full Text] [Related]
7. Eye movements and association with regional brain atrophy in clinical subtypes of progressive supranuclear palsy.
Choi JH; Kim H; Shin JH; Lee JY; Kim HJ; Kim JM; Jeon B
J Neurol; 2021 Mar; 268(3):967-977. PubMed ID: 32959131
[TBL] [Abstract][Full Text] [Related]
8. The Role of Rehabilitation in Patients With Progressive Supranuclear Palsy: A Narrative Review.
Intiso D; Bartolo M; Santamato A; Di Rienzo F
PM R; 2018 Jun; 10(6):636-645. PubMed ID: 29366918
[TBL] [Abstract][Full Text] [Related]
9. Erratum.
Mult Scler; 2016 Oct; 22(12):NP9-NP11. PubMed ID: 26041800
[TBL] [Abstract][Full Text] [Related]
10. Correlation between qualitative balance indices, dynamic posturography and structural brain imaging in patients with progressive supranuclear palsy and its subtypes.
Pasha SA; Yadav R; Ganeshan M; Saini J; Gupta A; Sandhya M; Pal PK
Neurol India; 2016; 64(4):633-9. PubMed ID: 27381106
[TBL] [Abstract][Full Text] [Related]
11. Ayurvedic approach in the management of spinal cord injury: A case study.
Singh SK; Rajoria K
Anc Sci Life; 2015; 34(4):230-4. PubMed ID: 26283809
[TBL] [Abstract][Full Text] [Related]
12. Ayurvedic management of chronic constipation in Hirschsprung disease - A case study.
Singh SK; Rajoria K
J Ayurveda Integr Med; 2018; 9(2):131-135. PubMed ID: 29853328
[TBL] [Abstract][Full Text] [Related]
13. A Modified Progressive Supranuclear Palsy Rating Scale for Virtual Assessments.
Wills AM; Pantelyat A; Espay A; Chan J; Litvan I; Xie T; Dale ML; Gunzler SA; Tartaglia MC; Fox SH; Rodriguez-Porcel F; Sharma M; Lang AE; Boxer AL; ; Golbe LI
Mov Disord; 2022 Jun; 37(6):1265-1271. PubMed ID: 35363932
[TBL] [Abstract][Full Text] [Related]
14. Fluvoxamine for the treatment of depression and parkinsonism in progressive supranuclear palsy.
Miyaoka T; Seno H; Inagaki T; Horiguchi J
Int J Psychiatry Clin Pract; 2002; 6(1):45-7. PubMed ID: 24931891
[TBL] [Abstract][Full Text] [Related]
15. Minimal clinically important worsening on the progressive supranuclear Palsy Rating Scale.
Hewer S; Varley S; Boxer AL; Paul E; Williams DR;
Mov Disord; 2016 Oct; 31(10):1574-1577. PubMed ID: 27324431
[TBL] [Abstract][Full Text] [Related]
16. Improvement of gaze control after balance and eye movement training in patients with progressive supranuclear palsy: a quasi-randomized controlled trial.
Zampieri C; Di Fabio RP
Arch Phys Med Rehabil; 2009 Feb; 90(2):263-70. PubMed ID: 19236979
[TBL] [Abstract][Full Text] [Related]
17. Balance and eye movement training to improve gait in people with progressive supranuclear palsy: quasi-randomized clinical trial.
Zampieri C; Di Fabio RP
Phys Ther; 2008 Dec; 88(12):1460-73. PubMed ID: 18948373
[TBL] [Abstract][Full Text] [Related]
18. Safety and efficacy of tilavonemab in progressive supranuclear palsy: a phase 2, randomised, placebo-controlled trial.
Höglinger GU; Litvan I; Mendonca N; Wang D; Zheng H; Rendenbach-Mueller B; Lon HK; Jin Z; Fisseha N; Budur K; Gold M; Ryman D; Florian H;
Lancet Neurol; 2021 Mar; 20(3):182-192. PubMed ID: 33609476
[TBL] [Abstract][Full Text] [Related]
19. Treatment of progressive supranuclear palsy with autologous adipose tissue-derived mesenchymal stem cells: a case report.
Choi SW; Park KB; Woo SK; Kang SK; Ra JC
J Med Case Rep; 2014 Mar; 8():87. PubMed ID: 24594311
[TBL] [Abstract][Full Text] [Related]
20. Long-term locomotor training for gait and balance in a patient with mixed progressive supranuclear palsy and corticobasal degeneration.
Steffen TM; Boeve BF; Mollinger-Riemann LA; Petersen CM
Phys Ther; 2007 Aug; 87(8):1078-87. PubMed ID: 17578939
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
